Comparative Hazards of Ocular Surface Disorders with IL-4/13 versus IL-13 Inhibitors in Atopic Dermatitis: A TriNetX Database Study - PubMed
9 hours ago
- #atopic dermatitis
- #interleukin inhibitors
- #ocular surface disorder
- Study compares ocular surface disorder risks between IL-4/13 and IL-13 inhibitors in atopic dermatitis patients.
- Research utilizes the TriNetX database for analysis.
- Keywords include atopic dermatitis, dupilumab, interleukin-13, interleukin-4, lebrikizumab, ocular surface disorder, and tralokinumab.